Conversion of a tumor-binding peptide identified by phage display to a functional chimeric T cell antigen receptor.
about
Combinatorial peptide libraries: mining for cell-binding peptides.Antibodies specifically target AML antigen NuSAP1 after allogeneic bone marrow transplantation.CAR-modified T-cell therapy for cancer: an updated review.Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptor.Chimeric antigen receptors for T cell immunotherapy: current understanding and future directionsTumor-targeting peptides from combinatorial libraries.Immunotherapy of malignant disease using chimeric antigen receptor engrafted T cellsGenetic modification of T cells for immunotherapy.Immunotherapy targeting EBV-expressing lymphoproliferative diseasesChimeric antibody receptors (CARs): driving T-cell specificity to enhance anti-tumor immunityTargeting of Aberrant αvβ6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells.Genetic redirection of T cells for cancer therapy.Chimeric antigen receptor-engineered T cells for immunotherapy of cancer.Chimeric antigen receptor (CAR)-engineered lymphocytes for cancer therapy.Design and implementation of adoptive therapy with chimeric antigen receptor-modified T cells.CAR T-cell immunotherapy: The path from the by-road to the freeway?A dual chain chimeric antigen receptor (CAR) in the native antibody format for targeting immune cells towards cancer cells without the need of an scFv.Engineering Chimeric Antigen Receptor T-Cells for Racing in Solid Tumors: Don't Forget the FuelEngineering Chimeric Antigen Receptors.VEGFR2-specific FnCAR effectively redirects the cytotoxic activity of T cells and YT NK cells.
P2860
Q31144876-2B378F1D-D1C9-4743-81A2-29105D0DDDFBQ33722678-9A79C32A-4F42-4271-A6F1-BF77E556B9BAQ34044213-F2BEB75E-418C-423C-A027-68737EE608B9Q34122292-2B1332DE-31FF-4D3A-9402-50D137E3A4E8Q34248531-C3E98FFE-3B70-4F8C-889D-E157F315F747Q36025723-0C148AD1-491D-4610-8147-0F9B90E9F59AQ36470354-1CD64A18-9143-47E7-99D4-C8D9E9E336C8Q36909362-F08FE806-0DD4-41BD-AB99-A66CA9D9C853Q37268305-FDE00FB1-4361-41B8-8405-25AD4A27BCF9Q37469199-4233445D-FB20-4460-8C02-ADA7B8184F92Q37603527-0D2DB3CF-3B56-4CDC-A613-DDD47FB91372Q37697337-B8DDDFCC-5D0A-483A-A1E6-400973210E8FQ37751873-D821832F-7C2A-4203-942D-08F8919382CDQ37861192-F8567542-E3FF-4AC0-AB53-E79491AA1419Q38170500-43846065-D9E2-4F97-B645-220AA7FC7101Q38632105-3E6005CB-2858-49C7-B896-91528611C933Q38760913-16DEC3D5-6BEB-4195-92FD-C61E96FB63D3Q39249589-81718DFE-EC5E-407A-8BC8-1178CE997B2AQ39276909-67FC2DE8-A46F-417F-928D-652F278A1B8BQ55129555-3157EAA9-1EA1-4EF9-A7D5-44F5DE3D2634
P2860
Conversion of a tumor-binding peptide identified by phage display to a functional chimeric T cell antigen receptor.
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Conversion of a tumor-binding ...... meric T cell antigen receptor.
@ast
Conversion of a tumor-binding ...... meric T cell antigen receptor.
@en
Conversion of a tumor-binding ...... meric T cell antigen receptor.
@nl
type
label
Conversion of a tumor-binding ...... meric T cell antigen receptor.
@ast
Conversion of a tumor-binding ...... meric T cell antigen receptor.
@en
Conversion of a tumor-binding ...... meric T cell antigen receptor.
@nl
prefLabel
Conversion of a tumor-binding ...... meric T cell antigen receptor.
@ast
Conversion of a tumor-binding ...... meric T cell antigen receptor.
@en
Conversion of a tumor-binding ...... meric T cell antigen receptor.
@nl
P2093
P2860
P356
P1433
P1476
Conversion of a tumor-binding ...... imeric T cell antigen receptor
@en
P2093
Meechoovet B
Pameijer CR
P2860
P2888
P356
10.1038/SJ.CGT.7700993
P577
2006-10-06T00:00:00Z